ALS | CON | Statistical significance | |
---|---|---|---|
Sample size | 73 | 100 | |
Age, mean (SD), years | 49.8 (7.9) | 49.8 (8.7) | t = 0.98, n.s |
Sex (female/male) | 33/40 | 57/43 | χ2 = 1.9, n.s |
Education level, mean (SD), years | 9.0 (3.2) | 8.9 (4.1) | t = -0.16, n.s |
BMI, mean (SD) | 22.4 (2.7) | 22.9 (2.8) | t = -1.3, n.s |
Bulbar onset (%) | 23.5% | n.a | |
Disease duration, mean (SD), months | 10.58 (5.86) | n.a | |
Progression rate, mean (SD), units/montha | 0.71 (0.63) | n.a | |
Exposure to toxic substances (yes/no)b | 15/58 | n.a | |
Anxiety level, mean (SD)c | 4.1 (5.2) | n.a | |
Depression level, mean (SD)d | 7.2 (7.2) | n.a | |
ALSFRS-R, mean (SD) | 42.0 (3.9) | n.a | |
ALSFRS-R_bulbar, mean (SD)e | 10.8 (1.8) | n.a | |
ALSFRS-R_motor, mean (SD)f | 19.1 (3.5) | n.a | |
ALSFRS-R_resp mean (SD)g | 12 (0) | n.a |